During the last session, Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s traded shares were 7.72 million, with the beta value of the company hitting 1.03. At the end of the trading day, the stock’s price was $0.10, reflecting an intraday loss of -2.46% or -$0.01. The company’s market capitalization is $5.92M, and the average intraday trading volume over the past 10 days was 48.59 million shares, and the average trade volume was 25.79 million shares over the past three months.
Cns Pharmaceuticals Inc (NASDAQ:CNSP) trade information
Cns Pharmaceuticals Inc (CNSP) registered a -2.46% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -2.46% in intraday trading to $0.10, hitting a weekly high. The stock’s 5-day price performance is -4.01%, and it has moved by -8.04% in 30 days. Based on these gigs, the overall price performance for the year is -99.74%. The short interest in Cns Pharmaceuticals Inc (NASDAQ:CNSP) is 1.14 million shares and it means that shorts have 0.04 day(s) to cover.
The consensus price target of analysts on Wall Street is $0.5, which implies an increase of 80.0% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $0.5 and $0.5 respectively. As a result, CNSP is trading at a discount of -400.0% off the target high and -400.0% off the low.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 17.98%.
CNSP Dividends
Cns Pharmaceuticals Inc is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Cns Pharmaceuticals Inc (NASDAQ:CNSP)’s Major holders
Cns Pharmaceuticals Inc insiders own 1.04% of total outstanding shares while institutional holders control 0.79%, with the float percentage being 0.80%.
Also, the Mutual Funds coming in first place with the largest holdings of Cns Pharmaceuticals Inc (CNSP) shares are Fidelity Extended Market Index Fund and Fidelity Series Total Market Index Fund . Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 161.12 shares. This amounts to just over 0.21 percent of the company’s overall shares, with a $16595.0 market value. The same data shows that the other fund manager holds slightly less at 37.94, or about 0.05% of the stock, which is worth about $3908.0.
